Cybin Inc. Common Stock
NASDAQ: HELP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael F. Cola
- Employees
- 50
- Headquarters
- Toronto, Canada
- IPO year
- 2019
- Market cap
- $254.0M
- Website
- http://www.cybin.com
Loading HELP…
Loading profile data…Frequently asked questions about HELP
What does Cybin Inc. Common Stock (HELP) do?
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT com...
Where does HELP trade?
Cybin Inc. Common Stock (HELP) trades on the NASDAQ Global Market.
What sector is HELP in?
Cybin Inc. Common Stock (HELP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cybin Inc. Common Stock?
Michael F. Cola is the chief executive officer of Cybin Inc. Common Stock (HELP).
Where is Cybin Inc. Common Stock headquartered?
Cybin Inc. Common Stock is headquartered in Canada.
Does HELP pay a dividend?
Cybin Inc. Common Stock (HELP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HELP go public?
Cybin Inc. Common Stock (HELP) completed its initial public offering in 2019.